Sionna Therapeutics, Inc. (NASDAQ:SION) is one of the best small cap stocks to buy for 10x potential. Wedbush initiated ...
Over the 3 months period, Vertex Pharmaceuticals showcased positive performance, achieving a revenue growth rate of 9.5 ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Investor's Business Daily on MSN
Vertex dips on mixed first-quarter report; but there's a silver lining
Vertex stock skidded Tuesday on a mixed first-quarter report, but analysts remain more interested in the company's R&D plans.
Vertex, BioMarin, and IQVIA reported Q1 2026 results showing revenue growth but varied earnings outcomes. Vertex posted 8% revenue growth to $2.99 billion, BioMarin saw a 3% revenue rise but missed ...
Over the past three decades, meaningful progress has been made in the research and understanding of cystic fibrosis (CF). 1 ...
Vertex Pharmaceuticals on Monday beat Wall Street estimates for first-quarter adjusted profit, helped by a near eight-fold ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now. On April 13, ...
Topline data is on track for anticipated readout in the summer of 2026WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- ...
By Leslie Herod Since its inception, Colorado’s Prescription Drug Affordability Board (PDAB) created fear among patients around effects to life-saving medicines and the negative ramifications price ...
VRTX heads into Q1 earnings with Trikafta demand, rising Alyftrek sales, and Casgevy and Journavx sales in focus ahead of the May 4 report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results